Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Själander

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lakartidningen|December 5, 2018
Sara Själander, Anders Själander
Journal of Thrombosis and Thrombolysis|September 13, 2023
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulantsJohan Lilja, Anders Själander, Sara Själander
International Journal of Cardiology|April 30, 2016
Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversionSara Själander, Peter J Svensson, Leif Friberg
Cardiovascular Therapeutics|January 13, 2022
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure PopulationErik Håkansson, Helena Norberg, Sara Själander, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 26, 2013
Atrial fibrillation patients do not benefit from acetylsalicylic acidSara Själander, Anders Själander, Peter J Svensson, et al.
Open Heart|January 5, 2023
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional studyErik Håkansson, Mattias Brunström, Helena Norberg, et al.
Thrombosis Research|May 28, 2018
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillationSara Själander, Vilhelm Sjögren, Henrik Renlund, et al.
Scandinavian Cardiovascular Journal : SCJ|June 16, 2026
Body size in young adulthood is associated with thoracic aortic events later in lifeLinn Skoglund Larsson, Sara Själander, Lars Johansson, et al.
Thrombosis Research|December 13, 2012
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed dosesBartosz Grzymala-Lubanski, Sara Själander, Henrik Renlund, et al.
BMJ Open|July 15, 2025
Increased direct oral anticoagulant use and event rates in non-valvular atrial fibrillation: a nationwide retrospective registry study in SwedenHayder Kadhim, Martin Jansson, Sara Själander, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lakartidningen|December 5, 2018
Sara Själander, Anders Själander
Journal of Thrombosis and Thrombolysis|September 13, 2023
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulantsJohan Lilja, Anders Själander, Sara Själander
International Journal of Cardiology|April 30, 2016
Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversionSara Själander, Peter J Svensson, Leif Friberg
Cardiovascular Therapeutics|January 13, 2022
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure PopulationErik Håkansson, Helena Norberg, Sara Själander, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 26, 2013
Atrial fibrillation patients do not benefit from acetylsalicylic acidSara Själander, Anders Själander, Peter J Svensson, et al.
Open Heart|January 5, 2023
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional studyErik Håkansson, Mattias Brunström, Helena Norberg, et al.
Thrombosis Research|May 28, 2018
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillationSara Själander, Vilhelm Sjögren, Henrik Renlund, et al.
Scandinavian Cardiovascular Journal : SCJ|June 16, 2026
Body size in young adulthood is associated with thoracic aortic events later in lifeLinn Skoglund Larsson, Sara Själander, Lars Johansson, et al.
Thrombosis Research|December 13, 2012
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed dosesBartosz Grzymala-Lubanski, Sara Själander, Henrik Renlund, et al.
BMJ Open|July 15, 2025
Increased direct oral anticoagulant use and event rates in non-valvular atrial fibrillation: a nationwide retrospective registry study in SwedenHayder Kadhim, Martin Jansson, Sara Själander, et al.
Pageof 2